Detection of 14 High-Risk Human Papillomaviruses Using Digital LAMP Assays on a Self-Digitization Chip

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Cervical cancer is a leading cause of cancer deaths in women globally, particularly in developing nations.
• High-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer.
• Current HPV detection methods like real-time PCR are costly and require extensive equipment, limiting their use in low-resource areas.

Purpose of the Study:

• To evaluate a novel digital loop-mediated isothermal amplification (dLAMP) assay for detecting high-risk HPV.
• To assess the performance of a microfluidic self-digitization chip integrated with the dLAMP assay.
• To determine the suitability of the dLAMP platform for rapid, low-cost HPV diagnosis in clinical samples.

Main Methods:

• Development of a digital loop-mediated isothermal amplification (dLAMP) assay for nucleic acid detection without thermocycling.
• Utilization of a microfluidic self-digitization chip to partition samples into nanoliter wells.
• Evaluation of the dLAMP assay and chip for detecting 14 common high-risk HPV types in clinical specimens.

Main Results:

• The dLAMP platform successfully performed rapid, quantitative detection of the 14 high-risk HPV types.
• The assay demonstrated high sensitivity in identifying HPV genotypes.
• The integrated self-digitization chip enabled reliable sample partitioning for analysis.

Conclusions:

• The dLAMP assay combined with a self-digitization chip is a sensitive and reliable method for HPV detection.
• This platform offers a potential solution for simple, rapid, and affordable HPV diagnosis.
• The technology holds significant promise for improving cervical cancer screening in resource-limited settings.